氧化三甲胺与老年慢性心力衰竭相关性的研究进展

doi:10.3969/j.issn.1003-9198.2022.01.024

摘要/Abstract

中图分类号:

R 541

王章, 邬真力. 氧化三甲胺与老年慢性心力衰竭相关性的研究进展[J]. 实用老年医学, 2022, 36(1): 91-94.

[1] 吴丽馨,马丽芳,王双,等.老年人肠道微生态与心力衰竭相关性的研究[J].中华老年医学杂志, 2020, 39(7):850-852.
[2] ADAK A, KHAN M R. An insight into gut microbiota and its functionalities[J].Cell Mol Life Sci, 2019, 76(3): 473-493.
[3] MANASA J S, TALUKDAR R, SUBRAMANYAM C, et al. Role of the normal gut microbiota[J]. World J Gastroentero, 2015, 21(29): 8787-803.
[4] 张炳山,郁志明,洪侃.衰弱与肠道微生物[J].实用老年医学, 2020, 34(6): 617-623.
[5] TICINESI A, TANA C, NOUVENNE A, et al. The intestinal microbiome and its relevance for functionality in older persons[J]. Curr Opin Clin Nutr Metab Care, 2019, 22(1): 4-12.
[6] SALAZAR N, VALDÉS-VARELA L, GONZÁLEZ S, et al. Nutrition and the gut microbiome in the elderly[J]. Gut Microbes, 2017, 8(2): 82-97.
[7] POLSINELLI V B, SINHA A, SHAH S J. Visceral congestion in heart failure: right ventricular dysfunction, splanchnic hemodynamics, and the intestinal microenvironment[J]. Curr Heart Fail Rep, 2017, 14(6): 519-528.
[8] GIL-CRUZ C, PEREZ-SHIBAYAMA C, MARTIN A D, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy[J]. Science, 2019, 366(6467): 881-886.
[9] 李飞翔,赵阳.老年冠心病合并心力衰竭患者肠道菌群特征性研究[J].中华老年医学杂志, 2019, 38(11):1220-1222.
[10] HAYASHI T, YAMASHITA T, WATANABE H,et al. Gut microbiome and plasma microbiome-related metabolites in patients with decompensated and compensated heart failure[J]. Circ J, 2019, 83(1): 182-192.
[11] ZHOU H, QIAN H. Relationship between enteral nutrition and serum levels of inflammatory factors and cardiac function in elderly patients with heart failure[J].Clin Interv Aging, 2018, 13:397-401.
[12] CHIONCEL O, AMBROSY A P. Trimethylamine N‐oxide and risk of heart failure progression: marker or mediator of disease[J]. Eur J Heart Fail, 2019, 21(7): 887-890.
[13] JENS O, ABITZ W S, SCHMIDT H T, et al. Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer[J]. Curr Pharm Des, 2017, 23(25): 3699-3712.
[14] TANG W H. We are not alone: understanding the contributions of intestinal microbial communities and the congested gut in heart failure[J]. Jacc Heart Failure, 2016, 4(3): 228-229.
[15] YANG W, ZHANG S, ZHU J, et al. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis[J]. J Mol Cell Cardiol, 2019, 134:119-130.
[16] TANG W H, WANG Z, FAN Y, et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis[J]. J Am Coll Cardiol, 2014, 64(18): 1908-1914.
[17] YUE C, YANG X, LI J, et al. Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells[J]. Biochem Biophys Res Commun, 2017, 490(2): 541-551.
[18] WANG Z, ROBERTS A B, BUFFA J A, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis[J]. Cell, 2015, 163(7): 1585-1595.
[19] DIN A U, HASSAN A, ZHU Y, et al. Amelioration of TMAO through probiotics and its potential role in atherosclerosis[J]. Appl Microbiol Biotechnol, 2019, 103(23-24): 9217-9228.
[20] 李伟,赵翠,王国玉,等. 肠内营养对老年慢性心力衰竭病人营养状态、心功能及炎性因子的影响[J].实用老年医学, 2019, 33(7): 646-649.
[21] 杨云梅.老年肠道微生态新进展[J].中华保健医学杂志, 2016, 18(1):1-6.
[22] LIU J, LIT X,WU H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulating TMAO level and CD4+ T cell induced-type I inflammation[J]. Biomed Pharmacother, 2019, 112:108580.
[23] JIA Q, LI H, ZHOU H, et al. Role and effective therapeutic target of gut microbiota in heart failure[J]. Cardiovasc Ther, 2019, 2019:5164298.
[24] BU J, WANG Z H. Cross-talk between gut microbiota and heart via the routes of metabolite and immunity[J]. Gastroenterol Res Pract, 2018, 2018:6458094.
[25] CHEN X, LI H Y, HU X M, et al. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure[J]. Chin Med J (Engl),2019, 132(15): 1843-1855.
[26] NAGATOMO Y, TANG W H W. Intersections between microbiome and heart failure: revisiting the gut hypothesis[J]. J Card Fail, 2015, 21(12): 973-980.
[27] ASCHER S, REINHARDT C. The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease[J]. Eur J Immunol, 2018, 48(4): 564-575.

氧化三甲胺与老年慢性心力衰竭相关性的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	李晓燕, 郁志明. 老年心房颤动合并焦虑状态的研究进展[J]. 实用老年医学, 2024, 38(10): 979-982.
[2]	顾崇怀, 项学军, 郑元喜, 乔锐, 林松. 达格列净对接受冠状动脉介入治疗的伴有射血分数降低的心力衰竭合并2型糖尿病老年病人疗效观察[J]. 实用老年医学, 2024, 38(10): 1025-1029.
[3]	刘瑾, 黄艳秋, 朱毅, 卓莉莉. 沙库巴曲缬沙坦钠对老年慢性心力衰竭病人的影响[J]. 实用老年医学, 2024, 38(10): 1030-1033.
[4]	徐寿勇, 袁勇. 老年病人开展双低剂量CT冠状动脉造影的可行性研究[J]. 实用老年医学, 2024, 38(10): 1054-1058.
[5]	刘琳, 邬青, 张静, 毛芳莹, 余璐, 任艺婷, 方婷. 老年心力衰竭病人症状感知现状及影响因素分析[J]. 实用老年医学, 2024, 38(5): 461-437.
[6]	刘倩慧, 姚子俊, 何玉立, 徐云凡, 吴军. 老年2型糖尿病合并慢性心力衰竭病人HbA1c水平对心脏结构和功能的影响[J]. 实用老年医学, 2024, 38(5): 491-437.
[7]	张丽莉, 李静, 丁林锋, 孙静娴, 蔡静波. 颈动脉粥样硬化斑块对非瓣膜性心房颤动病人缺血性脑卒中事件的预测价值[J]. 实用老年医学, 2024, 38(3): 236-239.
[8]	查志敏, 刘欢, 王向明, 李秋爽, 郭妍. 心脏瓣膜钙化对老年冠心病病人预后的影响[J]. 实用老年医学, 2024, 38(3): 245-250.
[9]	朱晨晨, 秦海东. 斑块侵蚀在急慢性冠脉综合征发生发展中的作用[J]. 实用老年医学, 2024, 38(3): 308-311.
[10]	程清, 徐艳, 陈国飞, 邓心悦. 血清血管紧张素Ⅱ和一氧化氮水平与老年慢性心力衰竭病人认知功能障碍的相关性[J]. 实用老年医学, 2024, 38(2): 132-135.
[11]	章颖, 谢玲, 叶佳琦, 羌文慧, 严晓云, 姜英, 张清. 层粘连蛋白与老年急性心肌梗死病人主要不良心血管事件的相关性[J]. 实用老年医学, 2024, 38(2): 149-151.
[12]	任丽艳. 老年心力衰竭病人血清胆碱酯酶水平与心室重塑的相关性研究[J]. 实用老年医学, 2023, 37(12): 1238-1241.
[13]	刘离香, 刘永铭. 巨噬细胞在心力衰竭中的作用及相关治疗研究进展[J]. 实用老年医学, 2023, 37(12): 1270-1273.
[14]	陆昊, 邓慧, 王春, 戴阳, 王芹, 王青. 老年慢性心力衰竭稳定期病人心肺功能、运动耐力特征及NT-proBNP和TNT分析[J]. 实用老年医学, 2023, 37(11): 1138-1142.
[15]	杨雪, 甯春, 赵娟, 郝敬波, 杨荣礼. 生长分化因子15和细胞因子对老年冠心病合并衰弱病人的诊断价值[J]. 实用老年医学, 2023, 37(10): 1009-1013.